Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ABCM

Abcam (ABCM) Stock Price, News & Analysis

Abcam logo

About Abcam Stock (NASDAQ:ABCM)

Key Stats

Today's Range
$23.99
$23.99
50-Day Range
$23.07
$23.99
52-Week Range
$12.48
$25.32
Volume
3,300 shs
Average Volume
3.08 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Stock News Headlines

Tracking George Soros's 13F Portfolio - Q4 2023 Update
The centerpiece of Trump’s crypto’s masterplan …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”
Headwaters Capital Q4 2023 Investor Letter
Abcam plc (ABCM) Interactive Stock Chart - Yahoo Finance
Abcam-Danaher Deal Receives All Identified Clearances - Quick Facts
See More Headlines

ABCM Stock Analysis - Frequently Asked Questions

Abcam (ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at a price of $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abcam investors own include HubSpot (HUBS), Meta Platforms (META), Netflix (NFLX), Tesla (TSLA), Advanced Micro Devices (AMD), Bank of America (BAC) and ConocoPhillips (COP).

Company Calendar

Today
11/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ABCM
Fax
N/A
Employees
1,760
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$379.70 million
Cash Flow
$0.60 per share
Book Value
$3.92 per share

Miscellaneous

Free Float
213,842,000
Market Cap
$5.50 billion
Optionable
Optionable
Beta
0.86
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:ABCM) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners